Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI)

CUSIP: 68236X100

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
101,268,340
Total 13F shares
34,670,910
Share change
+2,727,316
Total reported value
$120,993,806
Put/Call ratio
6%
Price per share
$3.49
Number of holders
107
Value change
+$10,399,257
Number of buys
66
Number of sells
30

Security key

68236X100

Report period

Q3 2025

Institutions

107

Top holders

10

Top shareholders of TOI - Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Ravi Yang Sarin
13D/G 3/4/5
Ravi Sarin · Director
4.7%
4,109,771
$11,959,434 $0 26 Mar 2025
Richard A. Barasch
3/4/5
Director
2.6%
2,635,881
mixed-class rows
$5,488,459 12 Aug 2025
VANGUARD GROUP INC
13F
Company
4.2%
4,280,887
$8,775,819 30 Jun 2025
13F
TIFF ADVISORY SERVICES, LLC
13F
Company
3.6%
3,634,465
$7,450,653 30 Jun 2025
13F
BlackRock, Inc.
13F
Company
3.3%
3,306,904
$6,779,154 30 Jun 2025
13F
BALYASNY ASSET MANAGEMENT L.P.
13F
Company
2.5%
2,518,337
$5,162,591 30 Jun 2025
13F
JOSH ARNOLD INVESTMENT CONSULTANT, LLC
13F
Company
2.4%
2,446,550
$5,015,432 30 Jun 2025
13F
MARSHALL WACE, LLP
13F
Company
1.5%
1,476,946
$3,027,739 30 Jun 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.3%
1,279,443
$2,623,124 30 Jun 2025
13F
WEXFORD CAPITAL LP
13F
Company
1.1%
1,118,679
$2,293,290 30 Jun 2025
13F
CenterBook Partners LP
13F
Company
0.71%
715,899
$1,467,593 30 Jun 2025
13F
STATE STREET CORP
13F
Company
0.64%
646,257
$1,324,827 30 Jun 2025
13F
BRC Group Holdings, Inc.
13F
Company
0.46%
462,000
$947,100 30 Jun 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.45%
457,500
$937,875 30 Jun 2025
13F
NORTHERN TRUST CORP
13F
Company
0.41%
411,357
$843,282 30 Jun 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.4%
405,009
$830,268 30 Jun 2025
13F
Massar Capital Management, LP
13F
Company
0.39%
400,000
$820,000 30 Jun 2025
13F
FourWorld Capital Management LLC
13F
Company
0.39%
391,650
$802,883 30 Jun 2025
13F
FreeGulliver LLC
13F
Company
0.34%
343,800
$704,790 30 Jun 2025
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.27%
278,165
$570,238 30 Jun 2025
13F
Manatuck Hill Partners, LLC
13F
Company
0.25%
249,800
$512,090 30 Jun 2025
13F
Bank of New York Mellon Corp
13F
Company
0.25%
248,646
$509,724 30 Jun 2025
13F
Portolan Capital Management, LLC
13F
Company
0.22%
221,512
$454,100 30 Jun 2025
13F
Informed Momentum Co LLC
13F
Company
0.19%
195,837
$401,466 30 Jun 2025
13F
MORGAN STANLEY
13F
Company
0.17%
175,373
$359,514 30 Jun 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.15%
154,632
$316,996 30 Jun 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.15%
147,534
$302,445 30 Jun 2025
13F
Verition Fund Management LLC
13F
Company
0.14%
139,763
$286,514 30 Jun 2025
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.13%
126,985
$260,319 30 Jun 2025
13F
CITIZENS FINANCIAL GROUP INC/RI
13F
Company
0.12%
119,000
$243,950 30 Jun 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.11%
113,676
$233,036 30 Jun 2025
13F
BARCLAYS PLC
13F
Company
0.1%
103,670
$212,524 30 Jun 2025
13F
Saba Capital Management, L.P.
13F
Company
0.09%
94,264
$193,241 30 Jun 2025
13F
Graham Capital Management, L.P.
13F
Company
0.09%
86,206
$176,722 30 Jun 2025
13F
RHUMBLINE ADVISERS
13F
Company
0.08%
85,231
$174,719 30 Jun 2025
13F
Lee Financial Co
13F
Company
0.08%
81,362
$166,793 30 Jun 2025
13F
HighTower Advisors, LLC
13F
Company
0.08%
81,362
$166,792 30 Jun 2025
13F
Quadrature Capital Ltd
13F
Company
0.08%
79,753
$163,892 30 Jun 2025
13F
Mount Lucas Management LP
13F
Company
0.08%
77,000
$157,850 30 Jun 2025
13F
Nuveen, LLC
13F
Company
0.08%
76,672
$157,178 30 Jun 2025
13F
NATIONAL BANK OF CANADA /FI/
13F
Company
0.08%
76,013
$155,827 30 Jun 2025
13F
Fielder Capital Group LLC
13F
Company
0.07%
70,192
$143,894 30 Jun 2025
13F
WealthShield Partners, LLC
13F
Company
0.07%
70,154
$143,816 30 Jun 2025
13F
KINGSWOOD WEALTH ADVISORS, LLC
13F
Company
0.06%
64,400
$132,020 30 Jun 2025
13F
XTX Topco Ltd
13F
Company
0.05%
49,443
$101,358 30 Jun 2025
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.04%
44,700
$91,635 30 Jun 2025
13F
MetLife Investment Management, LLC
13F
Company
0.04%
39,945
$81,888 30 Jun 2025
13F
Invesco Ltd.
13F
Company
0.04%
38,708
$79,351 30 Jun 2025
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.04%
38,000
$77,900 30 Jun 2025
13F
Cubist Systematic Strategies, LLC
13F
Company
0.03%
34,697
$71,129 30 Jun 2025
13F

Institutional Holders of Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) as of Q3 2025

As of 30 Sep 2025, Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) was held by 107 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 34,670,910 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., DEERFIELD MANAGEMENT COMPANY, L.P., CenterBook Partners LP, Balyasny Asset Management L.P., Kanen Wealth Management LLC, WEXFORD CAPITAL LP, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, and UBS Group AG. This page lists 107 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
78
Q3 2025 holders
107
Holder diff
29
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 Value $ Q3 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .